Romero, A Hemophagocytic syndrome following alemtuzumab treatment for multiple sclerosis: A case report. [electronic resource] - Multiple sclerosis and related disorders May 2020 - 101973 p. digital Publication Type: Case Reports; Journal Article ISSN: 2211-0356 Standard No.: 10.1016/j.msard.2020.101973 doi Subjects--Topical Terms: AdultAlemtuzumab--adverse effectsHumansImmunologic Factors--adverse effectsLymphohistiocytosis, Hemophagocytic--chemically inducedMaleMultiple Sclerosis, Relapsing-Remitting--drug therapy